Newsroom | 2115 results

OTTAWA--(BUSINESS WIRE)--Health care staff represented by CUPE 870 will be holding a rally outside the Perley and Rideau Veterans' Health Centre to protest 38 job cuts at the residential care home, as workers demand better staffing levels to improve care. The cuts at the Perley are part of a wave of health care cuts across the province including at hospitals in Ottawa, Hamilton, Niagara and North Bay. CUPE is blaming the provincial government for insufficient funding as the Financial Accountabi...

GAITHERSBURG, Md.--(BUSINESS WIRE)--Dr. Linda Genen named CMO to further strengthen GeneDx’s commitment to delivering earlier answers and better outcomes through genomic insights....

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx announced a record-setting year for its research programs, reinforcing its position as the global leader in rare disease genomics....

TOKYO--(BUSINESS WIRE)--Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture to Shonan Health Innovation Park....

WASHINGTON--(BUSINESS WIRE)--CMMI has disrupted patient access, undermined providers, operated with little accountability, and wasted billions of taxpayer dollars....

ST. PAUL, Minn.--(BUSINESS WIRE)--A Minnesota jury awarded $65.5 million to a 37-year-old mother of three minor children after finding in her favor in a lawsuit against Johnson & Johnson, concluding that the company’s talc products exposed her to asbestos and contributed to her developing peritoneal mesothelioma, a cancer of the peritoneal lining in the stomach. The verdict follows a 13-day trial in Ramsey County District Court, where jurors heard evidence that Johnson & Johnson sold an...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced an agreement with the U.S. government that lowers costs for state Medicaid programs, encourages other wealthy countries to reward innovation, and increases opportunities for direct patient access. Under this agreement, Genentech is making commitments that address all four priorities set forth in the President’s July 31st letter. Genentech’s commitments include making many...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with the U.S. government designed to reduce drug costs for Americans, reinforcing the company’s long-standing commitment to U.S.-based innovation, affordability, and global health leadership. “This agreement reflects a foundational commitment to both affordability and future innovation, a commitment that we have long seen as essential to shaping the future of healthcare,” said Daniel O’Day, C...